4.7 Review

Nanozymes towards Personalized Diagnostics: A Recent Progress in Biosensing

Journal

BIOSENSORS-BASEL
Volume 13, Issue 4, Pages -

Publisher

MDPI
DOI: 10.3390/bios13040461

Keywords

nanozyme; point of care; peroxidase; oxidase; SOD; catalase; colorimetric; fluorescence; electrochemical; SERS

Ask authors/readers for more resources

This review summarizes the recent advancements in nanozymes and their applications in point-of-care biosensors. Nanozymes, as enzyme-mimicking components in biosensing systems, offer improved performance and miniaturization of sensors. Various nanomaterials have been explored for the development of nanozyme-based biosensors, and different sensing strategies have been implemented using nanozymes as signal-producing components. Challenges, such as stability and specificity, need to be addressed for wider applications. The integration of nanozymes into point-of-care diagnostics promises to revolutionize healthcare by enhancing the accuracy and sensitivity of diagnostic tools.
This review highlights the recent advancements in the field of nanozymes and their applications in the development of point-of-care biosensors. The use of nanozymes as enzyme-mimicking components in biosensing systems has led to improved performance and miniaturization of these sensors. The unique properties of nanozymes, such as high stability, robustness, and surface tunability, make them an attractive alternative to traditional enzymes in biosensing applications. Researchers have explored a wide range of nanomaterials, including metals, metal oxides, and metal-organic frameworks, for the development of nanozyme-based biosensors. Different sensing strategies, such as colorimetric, fluorescent, electrochemical and SERS, have been implemented using nanozymes as signal-producing components. Despite the numerous advantages, there are also challenges associated with nanozyme-based biosensors, including stability and specificity, which need to be addressed for their wider applications. The future of nanozyme-based biosensors looks promising, with the potential to bring a paradigm shift in biomolecular sensing. The development of highly specific, multi-enzyme mimicking nanozymes could lead to the creation of highly sensitive and low-biofouling biosensors. Integration of nanozymes into point-of-care diagnostics promises to revolutionize healthcare by improving patient outcomes and reducing costs while enhancing the accuracy and sensitivity of diagnostic tools.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available